KDR and ovarian cancer: Furthermore, heterotypic interactions of L1CAM-ECD from ovarian cancers and α3 integrins of endothelial cells, promotes angiogenesis through the vascular endothelial growth factor receptor 2 (VEGFR-2) [77].